A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam®/Kolbam® (Cholic Acid)

Trial Profile

A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam®/Kolbam® (Cholic Acid)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2017

At a glance

  • Drugs Cholic acid (Primary)
  • Indications Inborn genetic disorders; Infantile Refsum disease; Peroxisomal disorders; Zellweger syndrome
  • Focus Adverse reactions
  • Acronyms REPLACE Registry
  • Sponsors Retrophin
  • Most Recent Events

    • 28 Jun 2017 Planned primary completion date changed from 1 May 2030 to 1 Jul 2030.
    • 28 Jun 2017 Status changed from not yet recruiting to recruiting.
    • 18 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top